Cargando…
Quantification of Fucosylated Hemopexin and Complement Factor H in Plasma of Patients with Liver Disease
[Image: see text] Enhanced fucosylation has been suggested as a marker for serologic monitoring of liver disease and hepatocellular carcinoma (HCC). We present a workflow for quantitative site-specific analysis of fucosylation and apply it to a comparison of hemopexin (HPX) and complement factor H (...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American
Chemical
Society
2014
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222631/ https://www.ncbi.nlm.nih.gov/pubmed/25302577 http://dx.doi.org/10.1021/ac502727s |